Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INVO Fertility (IVF) Common Equity (2016 - 2025)

INVO Fertility (IVF) has disclosed Common Equity for 15 consecutive years, with $5.8 million as the latest value for Q3 2025.

  • On a quarterly basis, Common Equity rose 25184.59% to $5.8 million in Q3 2025 year-over-year; TTM through Sep 2025 was $5.8 million, a 25184.59% increase, with the full-year FY2024 number at $12.7 million, up 1327.77% from a year prior.
  • Common Equity was $5.8 million for Q3 2025 at INVO Fertility, up from $2.6 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $12.7 million in Q4 2024 to a low of -$1.7 million in Q2 2023.
  • A 5-year average of $2.9 million and a median of $2.4 million in 2021 define the central range for Common Equity.
  • Peak YoY movement for Common Equity: tumbled 150.81% in 2023, then surged 32744.56% in 2025.
  • INVO Fertility's Common Equity stood at $7.3 million in 2021, then crashed by 113.37% to -$977612.0 in 2022, then soared by 191.33% to $892825.0 in 2023, then surged by 1327.77% to $12.7 million in 2024, then plummeted by 54.12% to $5.8 million in 2025.
  • Per Business Quant, the three most recent readings for IVF's Common Equity are $5.8 million (Q3 2025), $2.6 million (Q2 2025), and $3.3 million (Q1 2025).